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PreviewsC3b as a ligand and have defects refer-
able to complement regulation of APCs
and B cells in addition to T cells. Notwith-
standing the systemic nature of their
defect, the observation of vaccine-spe-
cific antibody responses in which the
Th2 cell-dependent isotypes (human
immunoglobulin G4 [IgG4] and IgE) were
most diminished (Pekkarinen et al.,
2015) suggests that analyses of the func-
tional subsets of circulating Tfh or mem-
ory Tfh cells in people with mutated
CD46will be important. CD46 phenotypes
run the gamut from normal health in the
absence of CD46 expression to atypical
hemolytic uremic syndrome to some
patients with common variable immuno-
deficiency. Yet more broadly, then, un-
derstanding why the spectrum ofperturbations in adaptive immunity of
CD46-mutated people is so broad offers
the possibility of important insights into
the modifiers of phenotype in vivo and hu-
man susceptibility to disease.
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Expression of distinct homing receptors guides adaptive immune cells to antigen-rich tissue. In this
issue of Immunity, Komarowska et al. (2015) describe an autocrine loop that is initiated by cardiac-ex-
pressed hepatocyte growth factor to direct T cells into the heart during inflammation and cardiac trans-
plant rejection.T cells are the main determinants of
adaptive immunity. Their presence in
target tissue is regulated by the expres-
sion of distinct sets of adhesion and che-
mokine receptors and required to fulfill
their immunological function. Naive and
effector/memory T cells are distinguish-
able by their adhesion factor signatures:
naive T cells can home only to lymph no-
des (via CCR7, L-selectin, and the integ-
rin LFA-1), whereas antigen-experienced
T cells can travel to almost any tissue via
many chemokine receptors and adhe-
sion molecules (Ley, 2014; Mora and
von Andrian, 2006). In order to return to
the tissue where the antigen is present,
there must be tissue tropism to allow a
site-directed action of adaptive immu-
nity. This is best documented for homing
to the skin and the gastrointestinal tract.Migration of primed T effector/memory
cells to skin involves the chemokine
receptors CCR4, CCR10, and CCR8
(McCully et al., 2012). T cells activated
in the mesenteric lymph nodes display
higher expression of CCR9 and a4b7 in-
tegrin (Zabel et al., 1999), which allows
their subsequent homing to the gut.
Beyond these findings, it has been chal-
lenging to identify unique tissue-homing
signatures. For instance, T cell accumu-
lation in atherosclerosis has been pro-
posed to be dependent on a variety
of chemokines, including CCR5, CCR7,
CXCR3, and CXCL10 among others,
but observations mainly stem from global
knock-out mouse models. Because
these chemokine receptors are also ex-
pressed on other immune cells, such as
dendritic or myeloid cells, their specificrole in T cell homing remains unclear (Li
and Ley, 2015).
If adhesion and chemokine receptors
are indeed executing T cell homing,
then what are the mechanisms imprinting
T cells initially to recall the origin of the
antigen exposure? Do tissue-derived fac-
tors induce specific sets of adhesion fac-
tors on T cells? In this issue of Immunity,
Komarowska et al. (2015) set out to
address this experimentally, by investi-
gating the role of hepatocyte growth fac-
tor (HGF) in T cell homing to the heart.
Although it has been proposed previously
that the chemokine receptors CXCR3
(and its ligand CXCL10) as well as
CCR4 are contributing to T cell accumu-
lation during heart transplantation (Han-
cock et al., 2001; Hu¨ser et al., 2005), it
was unknown how the myocardium42, June 16, 2015 ª2015 Elsevier Inc. 979
Figure 1. HGF’s Proposed Mechanism in T Cell Cardiotropism
Hepatocyte growth factor (HGF) is expressed by healthy heart tissue and transported to lymph nodes,
possibly by dendritic cells or passively. Binding to its receptor c-Met on naive T cells (Tnt) induces
signaling by Akt-STAT3-dependent pathways, resulting in higher expression of c-Met itself and of the
chemokine receptors CXCR3 and CCR4. Under inflammatory conditions, cardiac tissue releases higher
levels of the chemokines CXCL10 and CCL4, which serve as signal for HGF-primed T (Thgf) cells to
home to the heart. Also, injured cardiac tissue releasesmoreHGF,which in turnmight retain T cells in close
proximity by increasing chemokine receptor expression on recruited T cells. This mechanismmight further
be supported by enhanced expression of some chemokines by Thgf, including CCL3-5, 17, and 22 (not
depicted).
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and differentiation of heart-specific
T cells and whether such imprinting
would take place in inflamed tissue or
the draining lymph nodes. Findings from
Komarowska et al. (2015) suggest that
HGF might be a master regulator of
T cell cardiotropism.
The centerpiece of Komarowska et al.
(2015)’s study is a series of in vitro and
in vivo experiments, in which a 7-day
treatment with HGF in parallel with
strong induction of TCR signaling via
anti-CD3 and anti-CD28 stimulation
enhanced responsiveness to the chemo-
kines CXCL10 and CCL22 in migration
assays in vitro, as well as directing cells
to the peritoneal cavity in mice. These ef-
fects were dependent on binding of HGF980 Immunity 42, June 16, 2015 ª2015 Elsevto its receptor c-Met and induction of an
intracellular signaling cascade involving
Akt and STAT3 engagement. In part,
c-Met ligation increases responsiveness
to the canonical G protein-coupled
(GPCR) chemokine receptor family path-
ways, which include the chemokine re-
ceptors CCR4 and CXCR3, which bind
CCL22 and CXCL10, respectively. That
these pathways are relevant is supported
by a loss of HGF’s migratory effects after
treatment with pertussis toxin, a potent
inhibitor of Gai-dependent chemokine
receptor signaling. However, the authors
surprisingly found that HGF-stimulated
T cells did not respond to CCL5, even
though its receptor CCR5 is expressed.
Instead, HGF induced secretion of several
chemokines, including CCL3, CCL4,ier Inc.CCL5, CCL17, and CCL22, and increased
expression of the chemokine receptors
CCR4 and CXCR3. The authors conclude
that this mechanism represents an auto-
crine loop, by which T cells—once primed
by HGF—stimulate both receptors and
their ligands to re-direct T cells to target
tissue.
Notably, HGF was not sufficient to
alter chemokine expression in T cells in
an immediate fashion. Instead, only a
prolonged and constant exposure during
7 days in vitro resulted in upregulation of
the HGF receptor c-Met and increased
susceptibility to HGF. Naive T cells ex-
pressed much lower amounts of c-Met
than activated T effector/memory cells.
The authors found that HGF is expressed
in cardiac tissue—presumably by cardio-
myocytes, although the exact cellular
source was not tested—but only after a
strong inflammatory stimulus such as
LPS and not under steady-state condi-
tions. In line with the author’s hypothesis,
adoptively transferred T cells that were
primed in vitro with HGF for 7 days
homed preferentially to the heart. An
additional set of experiments, in which
the relative contribution of the homing
receptors CXCR3, CCR4, and CCR5
was tested in knock-out mice, revealed
that these receptors acted synergistically
to direct adoptively transferred T cells
to the heart. Finally, the authors demon-
strated clinical relevance by showing
that treatment with the c-Met inhib-
itor PHA-665752 protected mice from
cardiac allograft rejection, but not from
skin allograft rejection—a finding that
further supports a tissue-specific role of
the proposed mechanism in disease.
This was confirmed in a sophisticated
human heart xenograft model, where hu-
man heart biopsies were transplanted
into scidmice followed by injection of hu-
man HGF-treated T cells. Confirming the
mouse work, HGF-primed T cells homed
preferentially to the heart, proposing that
these new findings might also be relevant
in humans.
A somewhat unanswered question in
the work from Komarowska et al. (2015)
is how the HGF-c-Met axis contributes
to sequential T cell priming and recall
events in cardiac immunity. The authors
propose that cardiac HGFmight be trans-
ported to draining lymph nodes and
deposited in close proximity of endothe-
lial and dendritic cells—supported by
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marker CD31 and the dendritic cell
marker CD11c by microscopy. It is
possible that dendritic cells take up HGF
and travel from the myocardium to lymph
nodes, but this was not formally tested.
The authors argue that T cells interacting
with HGF in lymph nodes will be primed
for a cardiotropic chemokine-receptor
signature during simultaneous antigen
presentationandco-stimulation (Figure1).
It is indeed plausible that expression
of cardiotropic chemokine receptors
might guide T cells into the heart. How-
ever, what is the role of enhanced chemo-
kine secretion by T cells in response to
HGF? Is this an autocrine loop that keeps
primed T cells in the lymph node for some
time or do HGF-treated cells exhaust
after prolonged HGF treatment and stop
chemokine secretion? The authors did
not test different durations of HGF stimu-
lation followed by an absence of HGF to
clarify this. Thus, it is possible that HGF
deposition in the injured myocardium
might induce the relevant chemokines
that serve as direct homing signals. In
the latter case, increased chemokine
and chemokine receptor expression by
T cells themselves would help to retain
T cells in the myocardium. Indeed, some
observations support the idea that fulldifferentiation into functional T effector/
memory cells might require antigen pre-
sentation and second activation in non-
lymphoid tissue (Ley, 2014). HGF might
be a co-factor required for such tissue-
specific activation and retention in the
heart.
Beyond the findings presented in the
current study, some remaining questions
will have to be answered in the future.
First, this study required anti-CD3 and
anti-CD28 stimulation to exert HGF’s acti-
vating effects on T cells, which raises the
question whether weaker TCR-signaling
events, as would be expected from natu-
ral antigen stimulation by APCs, would
induce the same cardiotropic signatures
in vivo. Second, the authors find that be-
sides CCR5, both CCR4 and CXCR3 are
required for T cell homing. This is unex-
pected, because T helper (Th) cell lineage
commitment typically results in modified
chemokine receptor expression, defining
CXCR3 as landmark of Th1 and CCR4
of Th2 cell polarization (Sallusto et al.,
1998).
Taken together, the results presented
by Komarowska et al. (2015) introduce a
new paradigm for cardiac T cell tropism.
In addition, the data are exciting because
they raise the potential to alter tissue-
tropism of T cells that might modulateImmunityT cell-mediated pathology in the heart—
and relevant therapeutic compounds are
already available.REFERENCES
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Atherosclerosis is a lipid-storage disease of arteries that is exacerbated by chronic inflammatory processes.
In this issue of Immunity, Hu et al. (2015) demonstrate that T cell responses in atherosclerotic lesions are
controlled in tertiary lymphoid organs in the arterial wall.Atherosclerosis is a multifactorial cardio-
vascular disease that is characterized by
elevated lipid amounts in the blood and
deposition of lipids in and subsequent
chronic inflammation of the arterial wall.
The immune system already detects smallchanges in the integrity of the blood
vessel wall and reacts with macrophage
and T cell infiltration into early sub-
endothelial ‘‘fatty streaks’’ (Hansson and
Hermansson, 2011). With progressive
deposition of low-density cholesteroland formation of cholesterol crystals,
more immune cells infiltrate the vascular
lesion, leading to enhanced production
of collagens and fibrotic remodeling
of the atherosclerotic plaque. Uncon-
trolled growth and destabilization of42, June 16, 2015 ª2015 Elsevier Inc. 981
